Evidence map›Paper›PMID 42216197›Full record

ArticleCritical care (London, England)2026

High vasopressor doses are associated with decreased tissue oxygenation in critically ill patients: a secondary analysis of a prospective cohort.

Patrick Rehn, Katharina Hölzl, Silvia Seidlitz, Ayca von Garrel, Tobias Hölle, Maik von der Forst, Alexander Studier-Fischer, Mascha Fiedler-Kalenka, Dania Fischer, Felix Cf Schmitt and 5 more

Abstract read
In one paragraph

Article in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Patrick RehnDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Katharina HölzlDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Silvia SeidlitzDivision of Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120, Germany.
Ayca von GarrelDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Tobias HölleDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Maik von der ForstDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Alexander Studier-FischerDivision of Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120, Germany.
Mascha Fiedler-KalenkaDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Dania FischerDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Felix Cf SchmittDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Christoph LichtensternDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Markus Alexander WeigandDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Lena Maier-HeinDivision of Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120, Germany.
Maximilian DietrichDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany.
Stephan KatzenschlagerDepartment of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, Heidelberg, 69120, Germany. Stephan.Katzenschlager@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite stabilizing macrocirculatory blood pressure, vasopressors may deleteriously affect microcirculatory perfusion in critically ill patients. As microcirculatory dysfunction is associated with adverse outcomes and objective bedside monitoring remains limited, hyperspectral imaging (HSI) has emerged as a promising noninvasive method to assess tissue oxygenation. This study investigated the association between load of vasoactive medication and microcirculatory impairment using HSI in critically ill patients.

methodsIn this secondary analysis of the prospective HySpec-ICU study, 502 surgical ICU patients were included. HSI measurements of the hand were performed on the day of admission to determine tissue oxygenation (StO₂) and other HSI variables. Multivariable linear regression and mediation analysis were employed to investigate the association between Norepinephrine Equivalent (NEE) and StO₂ and its impact on serum lactate levels.

resultsHigher NEE was independently associated with significantly lower StO₂ (B = - 0.0931, β=-0.193, p = 0.001), while MAP showed no significant correlation with StO₂. Patients in the highest NEE quartile (> 0.28) exhibited the lowest StO₂ and the highest 30-day mortality (41.8%). StO₂ partially mediated the relationship between vasopressor load and arterial lactate. StO₂ generally improved after shock reversal defined as NEE ≤ 0.05, lactate < 2mmol/l, MAP ≥ 65mmHg for at least 24 h (+ 5.8%, p < 0.001).

conclusionHigh vasopressor requirements are associated with impaired microcirculatory oxygenation of the hand regardless of systemic blood pressure. HSI provides an objective bedside tool to monitor these alterations, potentially identifying patients with persistent microcirculatory shock who require intensified therapy beyond macrohemodynamic targets.

Indexed as

OxygenVasoconstrictor AgentsAgedCohort StudiesCritical IllnessFemaleHumansIntensive Care UnitsMaleMicrocirculationMiddle AgedNorepinephrineOxygen SaturationProspective StudiesNorepinephrineOxygenVasoconstrictor AgentsCatecholaminesHyperspectralMicrocirculationPerfusionShockVasopressor

Identifiers

PMID42216197
PMCPMC13221758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.